0001209191-17-058427.txt : 20171031
0001209191-17-058427.hdr.sgml : 20171031
20171031160845
ACCESSION NUMBER: 0001209191-17-058427
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171030
FILED AS OF DATE: 20171031
DATE AS OF CHANGE: 20171031
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alles Mark J
CENTRAL INDEX KEY: 0001538897
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 171165805
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-30
0
0000816284
CELGENE CORP /DE/
CELG
0001538897
Alles Mark J
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
1
1
0
0
See Remarks
Stock Option (right to buy)
100.97
2017-10-30
4
A
0
33881
A
2027-10-30
Common Stock
33881
33881
D
Option is immediately exercisable and will vest in four equal annual installments, commencing on October 30, 2018.
The option was issued pursuant to the Company's 2017 Stock Incentive Plan.
Chief Executive Officer
/s/ Peter N. Kellogg, Attorney-in-Fact
2017-10-31